JP2019527547A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019527547A5 JP2019527547A5 JP2019500446A JP2019500446A JP2019527547A5 JP 2019527547 A5 JP2019527547 A5 JP 2019527547A5 JP 2019500446 A JP2019500446 A JP 2019500446A JP 2019500446 A JP2019500446 A JP 2019500446A JP 2019527547 A5 JP2019527547 A5 JP 2019527547A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- heteropolymer
- amino acids
- begins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022144508A JP2022172479A (ja) | 2016-07-07 | 2022-09-12 | Ｔｇｆベータスーパーファミリーホモ多量体およびその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662359614P | 2016-07-07 | 2016-07-07 | |
| US62/359,614 | 2016-07-07 | ||
| US201662404670P | 2016-10-05 | 2016-10-05 | |
| US62/404,670 | 2016-10-05 | ||
| PCT/US2017/040849 WO2018009624A1 (en) | 2016-07-07 | 2017-07-06 | Tgf-beta superfamily heteromultimers and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022144508A Division JP2022172479A (ja) | 2016-07-07 | 2022-09-12 | Ｔｇｆベータスーパーファミリーホモ多量体およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019527547A JP2019527547A (ja) | 2019-10-03 |
| JP2019527547A5 true JP2019527547A5 (enExample) | 2022-09-22 |
| JP7159148B2 JP7159148B2 (ja) | 2022-10-24 |
Family
ID=60913181
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019500446A Expired - Fee Related JP7159148B2 (ja) | 2016-07-07 | 2017-07-06 | Ｔｇｆベータスーパーファミリーホモ多量体およびその使用 |
| JP2022144508A Pending JP2022172479A (ja) | 2016-07-07 | 2022-09-12 | Ｔｇｆベータスーパーファミリーホモ多量体およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022144508A Pending JP2022172479A (ja) | 2016-07-07 | 2022-09-12 | Ｔｇｆベータスーパーファミリーホモ多量体およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20200071382A1 (enExample) |
| EP (1) | EP3481860A4 (enExample) |
| JP (2) | JP7159148B2 (enExample) |
| AU (2) | AU2017293778B2 (enExample) |
| CA (1) | CA3029890A1 (enExample) |
| WO (1) | WO2018009624A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3280435B1 (en) | 2015-04-06 | 2021-06-02 | Acceleron Pharma Inc. | Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereof |
| MA41919A (fr) | 2015-04-06 | 2018-02-13 | Acceleron Pharma Inc | Hétéromultimères alk4:actriib et leurs utilisations |
| CN113683708A (zh) | 2015-04-06 | 2021-11-23 | 阿塞勒隆制药公司 | 单臂i型和ii型受体融合蛋白和其用途 |
| AU2017338916B2 (en) | 2016-10-05 | 2022-03-24 | Acceleron Pharma Inc. | Variant ActRIIB proteins and uses thereof |
| CN110678195A (zh) | 2016-10-05 | 2020-01-10 | 阿塞勒隆制药公司 | ALK4:ActRIIB异多聚体及其用途 |
| AU2019262139A1 (en) * | 2018-05-03 | 2020-11-26 | Acceleron Pharma Inc. | Multispecific binders of TGFβ-superfamily ligands and uses thereof |
| US20220089683A1 (en) * | 2018-06-15 | 2022-03-24 | Acceleron Pharma Inc. | Bi-and tri-functional fusion proteins and uses thereof |
| CA3156007A1 (en) | 2019-09-27 | 2021-04-01 | Disc Medicine, Inc. | METHODS OF TREATING MYELOFIBROSE AND ASSOCIATED CONDITIONS |
| AU2021273014A1 (en) | 2020-05-13 | 2022-11-17 | AbbVie Deutschland GmbH & Co. KG | Anti-hemojuvelin (HJV) antibodies for treating anemia of chronic disease |
| ES3075793T3 (en) | 2020-05-13 | 2026-08-07 | Disc Medicine Inc | Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis |
| EP4433160A1 (en) | 2021-11-17 | 2024-09-25 | Disc Medicine, Inc. | Methods for treating anemia of kidney disease |
| WO2026125668A1 (en) * | 2024-12-13 | 2026-06-18 | Institut National de la Santé et de la Recherche Médicale | Peptide derived from endoglin for treating bleeding disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2686348B1 (en) | 2011-03-17 | 2015-12-30 | Ramot at Tel-Aviv University Ltd. | Bi- and monospecific, asymmetric antibodies and methods of generating the same |
| EP3549952A1 (en) * | 2011-04-20 | 2019-10-09 | Acceleron Pharma Inc. | Endoglin polypeptides and uses thereof |
| WO2014055869A1 (en) | 2012-10-05 | 2014-04-10 | Acceleron Pharma, Inc. | Treatment of cancer with alk1 antagonists |
| AU2014339898B2 (en) * | 2013-10-25 | 2020-07-23 | Acceleron Pharma, Inc. | Endoglin peptides to treat fibrotic diseases |
| AU2014388308A1 (en) * | 2014-03-28 | 2016-10-27 | Acceleron Pharma, Inc. | Use of activin receptor-like kinase 1 (ALK-1) antagonists in the treatment of cancer |
| WO2015160940A1 (en) | 2014-04-15 | 2015-10-22 | President And Fellows Of Harvard College | Bi-specific agents |
-
2017
- 2017-07-06 AU AU2017293778A patent/AU2017293778B2/en not_active Ceased
- 2017-07-06 EP EP17824864.7A patent/EP3481860A4/en not_active Withdrawn
- 2017-07-06 WO PCT/US2017/040849 patent/WO2018009624A1/en not_active Ceased
- 2017-07-06 US US16/315,338 patent/US20200071382A1/en not_active Abandoned
- 2017-07-06 CA CA3029890A patent/CA3029890A1/en active Pending
- 2017-07-06 JP JP2019500446A patent/JP7159148B2/ja not_active Expired - Fee Related
-
2022
- 2022-03-08 AU AU2022201603A patent/AU2022201603A1/en not_active Abandoned
- 2022-09-12 JP JP2022144508A patent/JP2022172479A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7617962B2 (ja) | バリアントＡｃｔＲＩＩＢタンパク質およびその使用 | |
| JP7203807B2 (ja) | シングルアームｉ型およびｉｉ型受容体融合タンパク質およびその使用 | |
| JP7037363B2 (ja) | Ｔｇｆベータスーパーファミリーｉ型およびｉｉ型受容体ヘテロ多量体およびその使用 | |
| JP7159148B2 (ja) | Ｔｇｆベータスーパーファミリーホモ多量体およびその使用 | |
| JP7504947B2 (ja) | Ｔｇｆ－ベータスーパーファミリーｉ型およびｉｉ型受容体ヘテロ多量体ならびにその使用 | |
| HK40078293A (en) | Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereof | |
| HK40057061A (en) | Single-arm type i and type ii receptor fusion proteins and uses thereof | |
| WO2019136043A1 (en) | Single-arm co-receptor fusion proteins and uses thereof | |
| HK1252958B (en) | Single-arm type i and type ii receptor fusion proteins and uses thereof | |
| HK40011178A (zh) | 变体actriib蛋白及其用途 | |
| HK1248733B (en) | Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereof | |
| HK1248732B (en) | Single-arm type i and type ii receptor fusion proteins and uses thereof |